annual EBITDA:
$45.70M+$36.03M(+372.80%)Summary
- As of today (May 21, 2025), DVAX annual EBITDA is $45.70 million, with the most recent change of +$36.03 million (+372.80%) on December 31, 2024.
- During the last 3 years, DVAX annual EBITDA has fallen by -$50.05 million (-52.27%).
- DVAX annual EBITDA is now -85.15% below its all-time high of $307.70 million, reached on December 31, 2022.
Performance
DVAX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$94.44M-$106.70M(-869.83%)Summary
- As of today (May 21, 2025), DVAX quarterly EBITDA is -$94.44 million, with the most recent change of -$106.70 million (-869.83%) on March 1, 2025.
- Over the past year, DVAX quarterly EBITDA has dropped by -$86.30 million (-1060.14%).
- DVAX quarterly EBITDA is now -171.12% below its all-time high of $132.79 million, reached on June 30, 2022.
Performance
DVAX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$40.59M-$86.30M(-188.82%)Summary
- As of today (May 21, 2025), DVAX TTM EBITDA is -$40.59 million, with the most recent change of -$86.30 million (-188.82%) on March 1, 2025.
- Over the past year, DVAX TTM EBITDA has dropped by -$62.77 million (-283.03%).
- DVAX TTM EBITDA is now -111.94% below its all-time high of $340.08 million, reached on September 30, 2022.
Performance
DVAX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
DVAX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +372.8% | -1060.1% | -283.0% |
| 3 y3 years | -52.3% | -360.4% | -132.6% |
| 5 y5 years | +140.1% | -2310.3% | +53.0% |
DVAX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -85.2% | +372.8% | -171.1% | at low | -111.9% | at low |
| 5 y | 5-year | -85.2% | +140.1% | -171.1% | at low | -111.9% | +58.5% |
| alltime | all time | -85.2% | +133.8% | -171.1% | at low | -111.9% | +70.0% |
DVAX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$94.44M(-869.8%) | -$40.59M(-188.8%) |
| Dec 2024 | $45.70M(+372.8%) | $12.27M(-47.3%) | $45.70M(+17.4%) |
| Sep 2024 | - | $23.28M(+27.3%) | $38.92M(+17.7%) |
| Jun 2024 | - | $18.29M(-324.7%) | $33.06M(+49.1%) |
| Mar 2024 | - | -$8.14M(-248.4%) | $22.18M(+129.4%) |
| Dec 2023 | $9.67M(-96.9%) | $5.48M(-68.5%) | $9.67M(-87.3%) |
| Sep 2023 | - | $17.43M(+135.2%) | $76.10M(-39.4%) |
| Jun 2023 | - | $7.41M(-135.9%) | $125.67M(-49.9%) |
| Mar 2023 | - | -$20.65M(-128.7%) | $251.05M(-18.5%) |
| Dec 2022 | $307.70M(+221.3%) | $71.92M(+7.4%) | $307.97M(-9.4%) |
| Sep 2022 | - | $66.99M(-49.5%) | $340.08M(+36.3%) |
| Jun 2022 | - | $132.79M(+266.1%) | $249.42M(+100.1%) |
| Mar 2022 | - | $36.27M(-65.1%) | $124.66M(+30.2%) |
| Dec 2021 | $95.75M(-304.4%) | $104.03M(-539.6%) | $95.75M(-657.5%) |
| Sep 2021 | - | -$23.66M(-394.9%) | -$17.18M(-198.5%) |
| Jun 2021 | - | $8.03M(+9.0%) | $17.43M(-149.0%) |
| Mar 2021 | - | $7.36M(-182.7%) | -$35.56M(-24.1%) |
| Dec 2020 | -$46.84M(-58.9%) | -$8.90M(-181.3%) | -$46.84M(-28.8%) |
| Sep 2020 | - | $10.94M(-124.3%) | -$65.78M(-32.7%) |
| Jun 2020 | - | -$44.97M(+1047.8%) | -$97.74M(+13.2%) |
| Mar 2020 | - | -$3.92M(-85.9%) | -$86.35M(-24.3%) |
| Dec 2019 | -$114.09M(-15.5%) | -$27.83M(+32.4%) | -$114.09M(-5.0%) |
| Sep 2019 | - | -$21.02M(-37.4%) | -$120.04M(-9.2%) |
| Jun 2019 | - | -$33.58M(+6.1%) | -$132.14M(-0.0%) |
| Mar 2019 | - | -$31.66M(-6.3%) | -$132.18M(-2.1%) |
| Dec 2018 | -$135.08M(+48.9%) | -$33.78M(+2.0%) | -$135.08M(+4.6%) |
| Sep 2018 | - | -$33.12M(-1.5%) | -$129.09M(+9.8%) |
| Jun 2018 | - | -$33.62M(-2.7%) | -$117.58M(+13.7%) |
| Mar 2018 | - | -$34.56M(+24.3%) | -$103.39M(+14.0%) |
| Dec 2017 | -$90.72M(-17.7%) | -$27.79M(+28.6%) | -$90.71M(+8.9%) |
| Sep 2017 | - | -$21.61M(+11.2%) | -$83.30M(-13.1%) |
| Jun 2017 | - | -$19.43M(-11.2%) | -$95.90M(-8.8%) |
| Mar 2017 | - | -$21.88M(+7.4%) | -$105.17M(-4.5%) |
| Dec 2016 | -$110.19M(+5.1%) | -$20.38M(-40.4%) | -$110.19M(-5.2%) |
| Sep 2016 | - | -$34.21M(+19.2%) | -$116.27M(+4.0%) |
| Jun 2016 | - | -$28.71M(+6.8%) | -$111.80M(+5.4%) |
| Mar 2016 | - | -$26.89M(+1.7%) | -$106.11M(+1.2%) |
| Dec 2015 | -$104.86M(+17.4%) | -$26.45M(-11.0%) | -$104.86M(+5.1%) |
| Sep 2015 | - | -$29.74M(+29.1%) | -$99.80M(-0.0%) |
| Jun 2015 | - | -$23.03M(-10.2%) | -$99.81M(-1.5%) |
| Mar 2015 | - | -$25.64M(+19.8%) | -$101.29M(+13.4%) |
| Dec 2014 | -$89.28M(+37.0%) | -$21.40M(-28.0%) | -$89.28M(+11.0%) |
| Sep 2014 | - | -$29.74M(+21.3%) | -$80.45M(+21.9%) |
| Jun 2014 | - | -$24.51M(+79.9%) | -$66.02M(+13.2%) |
| Mar 2014 | - | -$13.63M(+8.5%) | -$58.31M(-10.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | -$65.16M(-1.9%) | -$12.57M(-17.9%) | -$65.16M(-9.8%) |
| Sep 2013 | - | -$15.31M(-8.9%) | -$72.24M(-2.1%) |
| Jun 2013 | - | -$16.81M(-17.9%) | -$73.83M(+3.6%) |
| Mar 2013 | - | -$20.47M(+4.2%) | -$71.24M(+7.3%) |
| Dec 2012 | -$66.39M(+47.4%) | -$19.65M(+16.3%) | -$66.39M(+32.1%) |
| Sep 2012 | - | -$16.90M(+18.8%) | -$50.25M(+5.0%) |
| Jun 2012 | - | -$14.22M(-9.0%) | -$47.87M(+10.3%) |
| Mar 2012 | - | -$15.63M(+346.1%) | -$43.39M(-3.8%) |
| Dec 2011 | -$45.04M(-15.4%) | -$3.50M(-75.9%) | -$45.09M(-30.3%) |
| Sep 2011 | - | -$14.52M(+48.9%) | -$64.72M(+14.8%) |
| Jun 2011 | - | -$9.75M(-43.7%) | -$56.37M(-9.5%) |
| Mar 2011 | - | -$17.32M(-25.1%) | -$62.27M(+16.9%) |
| Dec 2010 | -$53.26M(+333.8%) | -$23.13M(+275.4%) | -$53.26M(+29.7%) |
| Sep 2010 | - | -$6.16M(-60.6%) | -$41.07M(-8.5%) |
| Jun 2010 | - | -$15.65M(+88.5%) | -$44.90M(+75.1%) |
| Mar 2010 | - | -$8.31M(-24.1%) | -$25.64M(+108.9%) |
| Dec 2009 | -$12.28M(-42.3%) | -$10.95M(+9.6%) | -$12.28M(-1048.1%) |
| Sep 2009 | - | -$9.99M(-377.4%) | $1.29M(-79.2%) |
| Jun 2009 | - | $3.60M(-28.8%) | $6.23M(-289.1%) |
| Mar 2009 | - | $5.06M(+92.6%) | -$3.29M(-84.5%) |
| Dec 2008 | -$21.29M(-69.0%) | $2.63M(-151.9%) | -$21.29M(-42.9%) |
| Sep 2008 | - | -$5.06M(-14.5%) | -$37.29M(-26.6%) |
| Jun 2008 | - | -$5.92M(-54.3%) | -$50.78M(-22.3%) |
| Mar 2008 | - | -$12.94M(-3.3%) | -$65.37M(-4.2%) |
| Dec 2007 | -$68.61M(+15.7%) | -$13.38M(-27.9%) | -$68.26M(-10.9%) |
| Sep 2007 | - | -$18.54M(-9.6%) | -$76.62M(+6.2%) |
| Jun 2007 | - | -$20.51M(+29.6%) | -$72.15M(+10.6%) |
| Mar 2007 | - | -$15.83M(-27.2%) | -$65.25M(+13.5%) |
| Dec 2006 | -$59.27M(+206.2%) | -$21.74M(+54.5%) | -$57.48M(+31.8%) |
| Sep 2006 | - | -$14.07M(+3.3%) | -$43.61M(+14.0%) |
| Jun 2006 | - | -$13.61M(+69.0%) | -$38.26M(+16.7%) |
| Mar 2006 | - | -$8.06M(+2.3%) | -$32.80M(+70.7%) |
| Dec 2005 | -$19.36M(+42.5%) | -$7.88M(-9.6%) | -$19.22M(+21.5%) |
| Sep 2005 | - | -$8.71M(+6.9%) | -$15.81M(+48.6%) |
| Jun 2005 | - | -$8.15M(-247.6%) | -$10.64M(+153.5%) |
| Mar 2005 | - | $5.52M(-223.5%) | -$4.20M(-69.1%) |
| Dec 2004 | -$13.59M(-21.0%) | -$4.47M(+26.4%) | -$13.59M(-49.7%) |
| Sep 2004 | - | -$3.54M(+107.3%) | -$27.00M(+15.2%) |
| Jun 2004 | - | -$1.71M(-55.8%) | -$23.43M(+8.3%) |
| Mar 2004 | - | -$3.87M(-78.4%) | -$21.63M(+21.8%) |
| Dec 2003 | -$17.19M(-4.4%) | -$17.88M(<-9900.0%) | -$17.76M(<-9900.0%) |
| Sep 2003 | - | $23.00K(-76.0%) | $119.00K(+24.0%) |
| Jun 2003 | - | $96.00K | $96.00K |
| Dec 2002 | -$17.98M(-7.9%) | - | - |
| Dec 2001 | -$19.53M(+66.7%) | - | - |
| Dec 2000 | -$11.72M | - | - |
FAQ
- What is Dynavax Technologies annual EBITDA?
- What is the all time high annual EBITDA for Dynavax Technologies?
- What is Dynavax Technologies annual EBITDA year-on-year change?
- What is Dynavax Technologies quarterly EBITDA?
- What is the all time high quarterly EBITDA for Dynavax Technologies?
- What is Dynavax Technologies quarterly EBITDA year-on-year change?
- What is Dynavax Technologies TTM EBITDA?
- What is the all time high TTM EBITDA for Dynavax Technologies?
- What is Dynavax Technologies TTM EBITDA year-on-year change?
What is Dynavax Technologies annual EBITDA?
The current annual EBITDA of DVAX is $45.70M
What is the all time high annual EBITDA for Dynavax Technologies?
Dynavax Technologies all-time high annual EBITDA is $307.70M
What is Dynavax Technologies annual EBITDA year-on-year change?
Over the past year, DVAX annual EBITDA has changed by +$36.03M (+372.80%)
What is Dynavax Technologies quarterly EBITDA?
The current quarterly EBITDA of DVAX is -$94.44M
What is the all time high quarterly EBITDA for Dynavax Technologies?
Dynavax Technologies all-time high quarterly EBITDA is $132.79M
What is Dynavax Technologies quarterly EBITDA year-on-year change?
Over the past year, DVAX quarterly EBITDA has changed by -$86.30M (-1060.14%)
What is Dynavax Technologies TTM EBITDA?
The current TTM EBITDA of DVAX is -$40.59M
What is the all time high TTM EBITDA for Dynavax Technologies?
Dynavax Technologies all-time high TTM EBITDA is $340.08M
What is Dynavax Technologies TTM EBITDA year-on-year change?
Over the past year, DVAX TTM EBITDA has changed by -$62.77M (-283.03%)